SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-752318
Filing Date
2016-10-31
Accepted
2016-10-31 06:17:03
Documents
3
Period of Report
2016-10-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d265444d8k.htm 8-K 18096
2 EX-3.1 d265444dex31.htm EX-3.1 3883
3 EX-3.2 d265444dex32.htm EX-3.2 6354
  Complete submission text file 0001193125-16-752318.txt   29862
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 161959927
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences